联环药业,600513,收入构成,报告日期,2020-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药制造,81932,15508,66424,81.07%,89.02% 医药流通,53557,45975,7583,14.16%,10.16% 其他(补充),1844,1476,368,19.94%,0.49% 其他,1271,1025,247,19.41%,0.33% 联环药业,600513,收入构成,报告日期,2014-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),128,272,-144,-112.06%,-0.88% 其他,139,130,9,6.41%,0.05% 针剂,5851,2019,3832,65.49%,23.54% 片剂,18391,7831,10560,57.42%,64.87% 原料药,9124,7103,2021,22.15%,12.41% 联环药业,600513,收入构成,报告日期,2009-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 泌尿外科用药,1322,448,874,66.13%,19.75% 心血管药物,2690,963,1727,64.21%,39.02% 抗过敏药物,3080,1255,1825,59.25%,41.23%